
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 24 August 2023
Sec. Molecular and Cellular Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1271492
This article is a correction to:
Multifunctions of CRIF1 in cancers and mitochondrial dysfunction
A Corrigendum on
Multifunctions of CRIF1 in cancers and mitochondrial dysfunction
by Jiang Y, Xiang Y, Lin C, Zhang W, Yang Z, Xiang L, Xiao Y, Chen L, Ran Q and Li Z (2022). Front. Oncol. 12:1009948. doi: 10.3389/fonc.2022.1009948
In the published article, there was an error in the Funding statement. The number for the funding from Chongqing Science and Technology Commission was incorrectly displayed as “No. 2021C035”, the correct number is “cstc2021jcyj-jqX0004”. The correct Funding statement appears below.
FUNDING
This work was supported by projects of the International Cooperation and Exchanges NSFC (No. 82020108025), National Natural Science Foundation of China (No. 81972973), and Chongqing Science and Technology Commission (cstc2021jcyj-jqX0004).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CR6-interacting factor 1, cell cycle regulation, cell proliferation regulation, cancer treatment, mitochondrial ribosomal protein, mitochondrial dysfunction
Citation: Jiang Y, Xiang Y, Lin C, Zhang W, Yang Z, Xiang L, Xiao Y, Chen L, Ran Q and Li Z (2023) Corrigendum: Multifunctions of CRIF1 in cancers and mitochondrial dysfunction. Front. Oncol. 13:1271492. doi: 10.3389/fonc.2023.1271492
Received: 02 August 2023; Accepted: 04 August 2023;
Published: 24 August 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Jiang, Xiang, Lin, Zhang, Yang, Xiang, Xiao, Chen, Ran and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qian Ran, bG91aXNlLXItcUAxNjMuY29t; Zhongjun Li, am9obm5leXVzY0BnbWFpbC5jb20=
†These authors have contributed equally to this work and share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.